Alsina MM - Search Results

1

The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.

Yoneda T, Lyall RM, Alsina MM, Persons PE, Spada AP, Levitzki A, Zilberstein A, Mundy GR. Yoneda T, et al. Among authors: alsina mm. Cancer Res. 1991 Aug 15;51(16):4430-5. Cancer Res. 1991. PMID: 1651159

2

Differentiation of HL-60 cells into cells with the osteoclast phenotype.

Yoneda T, Alsina MM, Garcia JL, Mundy GR. Yoneda T, et al. Among authors: alsina mm. Endocrinology. 1991 Aug;129(2):683-9. doi: 10.1210/endo-129-2-683. Endocrinology. 1991. PMID: 1649744

3

Porcine pancreas extract decreases blood-ionized calcium in mice and inhibits osteoclast formation and bone resorption in culture.

Yoneda T, Takaoka Y, Alsina MM, Garcia J, Mundy GR. Yoneda T, et al. Among authors: alsina mm. FEBS Lett. 1991 Jan 28;278(2):171-4. doi: 10.1016/0014-5793(91)80109-g. FEBS Lett. 1991. PMID: 1991507 Free article.

4

Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes.

Yoneda T, Aufdemorte TB, Nishimura R, Nishikawa N, Sakuda M, Alsina MM, Chavez JB, Mundy GR. Yoneda T, et al. Among authors: alsina mm. J Clin Oncol. 1991 Mar;9(3):468-77. doi: 10.1200/JCO.1991.9.3.468. J Clin Oncol. 1991. PMID: 1999718

5

Dependence of a human squamous carcinoma and associated paraneoplastic syndromes on the epidermal growth factor receptor pathway in nude mice.

Yoneda T, Alsina MM, Watatani K, Bellot F, Schlessinger J, Mundy GR. Yoneda T, et al. Among authors: alsina mm. Cancer Res. 1991 May 1;51(9):2438-43. Cancer Res. 1991. PMID: 2015605

6

An in vivo model of human multiple myeloma bone disease.

Alsina M, Boyce BF, Mundy GR, Roodman GD. Alsina M, et al. Stem Cells. 1995 Aug;13 Suppl 2:48-50. Stem Cells. 1995. PMID: 8520511

7

Development of an in vivo model of human multiple myeloma bone disease.

Alsina M, Boyce B, Devlin RD, Anderson JL, Craig F, Mundy GR, Roodman GD. Alsina M, et al. Blood. 1996 Feb 15;87(4):1495-501. Blood. 1996. PMID: 8608240 Free article.

8

Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.

Cruz JC, Alsina M, Craig F, Yoneda T, Anderson JL, Dallas M, Roodman GD. Cruz JC, et al. Exp Hematol. 2001 Apr;29(4):441-7. doi: 10.1016/s0301-472x(01)00618-x. Exp Hematol. 2001. PMID: 11301184 Free article.

9

Cytokine regulation of bone cell differentiation.

Alsina M, Guise TA, Roodman GD. Alsina M, et al. Vitam Horm. 1996;52:63-98. doi: 10.1016/s0083-6729(08)60407-0. Vitam Horm. 1996. PMID: 8909157 Review.

10

Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.

Yarde DN, Oliveira V, Mathews L, Wang X, Villagra A, Boulware D, Shain KH, Hazlehurst LA, Alsina M, Chen DT, Beg AA, Dalton WS. Yarde DN, et al. Cancer Res. 2009 Dec 15;69(24):9367-75. doi: 10.1158/0008-5472.CAN-09-2616. Cancer Res. 2009. PMID: 19934314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters